Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals
- PMID: 19852802
- PMCID: PMC2772840
- DOI: 10.1186/1475-2875-8-235
Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals
Abstract
Background: MB2 protein is a sporozoite surface antigen on the human malaria parasite Plasmodium falciparum. MB2 was identified by screening a P. falciparum sporozoite cDNA expression library using immune sera from a protected donor immunized via the bites of P. falciparum-infected irradiated mosquitoes. It is not known whether natural exposure to P. falciparum also induces the anti-MB2 response and if this response differs from that in protected individuals immunized via the bites of P. falciparum infected irradiated mosquitoes. The anti-MB2 antibody response may be part of a robust protective response against the sporozoite.
Methods: Fragments of polypeptide regions of MB2 were constructed as recombinant fusions sandwiched between glutathione S-transferase and a hexa histidine tag for bacterial expression. The hexa histidine tag affinity purified proteins were used to immunize rabbits and the polyclonal sera evaluated in an in vitro inhibition of sporozoite invasion assay. The proteins were also used in immunoblots with sera from a limited number of donors immunized via the bites of P. falciparum infected irradiated mosquitoes and plasma and serum obtained from naturally exposed individuals in Kenya.
Results: Rabbit polyclonal antibodies targeting the non-repeat region of the basic domain of MB2 inhibited sporozoites entry into HepG2-A16 cells in vitro. Analysis of serum from five human volunteers that were immunized via the bites of P. falciparum infected irradiated mosquitoes that developed immunity and were completely protected against subsequent challenge with non-irradiated parasite also had detectable levels of antibody against MB2 basic domain. In contrast, in three volunteers not protected, anti-MB2 antibodies were below the level of detection. Sera from protected volunteers preferentially recognized a non-repeat region of the basic domain of MB2, whereas plasma from naturally-infected individuals also had antibodies that recognize regions of MB2 that contain a repeat motif in immunoblots. Sequence analysis of eleven field isolates and four laboratory strains showed that these antigenic regions of the basic domain of the MB2 gene are highly conserved in parasites obtained from different parts of the world. Moreover, anti-MB2 antibodies also were detected in the plasma of 83% of the individuals living in a malaria endemic area of Kenya (n = 41).
Conclusion: A preliminary analysis of the human humoral response against MB2 indicates that it may be an additional highly conserved target for immune intervention at the pre-erythrocytic stage of P. falciparum life cycle.
Figures


Similar articles
-
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.Am J Trop Med Hyg. 1993 Aug;49(2):166-73. doi: 10.4269/ajtmh.1993.49.166. Am J Trop Med Hyg. 1993. PMID: 8357078
-
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.Eur J Immunol. 1997 Oct;27(10):2502-13. doi: 10.1002/eji.1830271007. Eur J Immunol. 1997. PMID: 9368603
-
Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.J Immunol. 1992 Oct 15;149(8):2695-701. J Immunol. 1992. PMID: 1401909
-
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:223-7. doi: 10.1590/s0074-02761992000700037. Mem Inst Oswaldo Cruz. 1992. PMID: 1364202 Review.
-
Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.Front Immunol. 2020 Feb 21;11:190. doi: 10.3389/fimmu.2020.00190. eCollection 2020. Front Immunol. 2020. PMID: 32153565 Free PMC article. Review.
Cited by
-
Antibody and B cell responses to Plasmodium sporozoites.Front Microbiol. 2014 Nov 18;5:625. doi: 10.3389/fmicb.2014.00625. eCollection 2014. Front Microbiol. 2014. PMID: 25477870 Free PMC article. Review.
-
A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions.Malar J. 2024 May 16;23(1):151. doi: 10.1186/s12936-024-04913-2. Malar J. 2024. PMID: 38755636 Free PMC article.
-
The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya.J Glob Infect Dis. 2013 Oct;5(4):131-7. doi: 10.4103/0974-777X.122001. J Glob Infect Dis. 2013. PMID: 24672173 Free PMC article.
-
Identifying Potential Plasmodium vivax Sporozoite Stage Vaccine Candidates: An Analysis of Genetic Diversity and Natural Selection.Front Genet. 2018 Jan 25;9:10. doi: 10.3389/fgene.2018.00010. eCollection 2018. Front Genet. 2018. PMID: 29422913 Free PMC article.
References
-
- Aregawi M, Cibulskis R, Otten M, Williams R, Dye C. World Malaria Report 2008. In: Aregawi M, Cibulskis R, Otten M, Williams R, Dye C, editor. WHO Global Malaria Programme. Geneva: World Health Organisation; 2008.
-
- Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg. 2004;71:239–247. - PubMed